ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $60,496 | -74.2% | 459,000 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $234,090 | -19.0% | 459,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $289,170 | -2.9% | 459,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $297,936 | -62.2% | 459,000 | 0.0% | 0.00% | -71.4% |
| Q3 2022 | $789,000 | +38.7% | 459,000 | 0.0% | 0.01% | +40.0% |
| Q2 2022 | $569,000 | +90.3% | 459,000 | 0.0% | 0.01% | +150.0% |
| Q1 2022 | $299,000 | -40.2% | 459,000 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $500,000 | -40.2% | 459,000 | -0.1% | 0.00% | -50.0% |
| Q3 2021 | $836,000 | -31.0% | 459,500 | +0.1% | 0.01% | -33.3% |
| Q2 2021 | $1,212,000 | -26.6% | 459,000 | 0.0% | 0.01% | -30.8% |
| Q1 2021 | $1,652,000 | +42.8% | 459,000 | 0.0% | 0.01% | +44.4% |
| Q4 2020 | $1,157,000 | -0.7% | 459,000 | -0.7% | 0.01% | -18.2% |
| Q3 2020 | $1,165,000 | -23.2% | 462,055 | 0.0% | 0.01% | -26.7% |
| Q2 2020 | $1,516,000 | +33.9% | 462,055 | 0.0% | 0.02% | +7.1% |
| Q1 2020 | $1,132,000 | -40.7% | 462,055 | +14.2% | 0.01% | -22.2% |
| Q4 2019 | $1,909,000 | +46.5% | 404,500 | +32.8% | 0.02% | +38.5% |
| Q3 2019 | $1,303,000 | -26.6% | 304,500 | 0.0% | 0.01% | -35.0% |
| Q2 2019 | $1,775,000 | +51.5% | 304,500 | 0.0% | 0.02% | +42.9% |
| Q1 2019 | $1,172,000 | +106.0% | 304,500 | 0.0% | 0.01% | +100.0% |
| Q4 2018 | $569,000 | -41.6% | 304,500 | 0.0% | 0.01% | -41.7% |
| Q3 2018 | $974,000 | +5.9% | 304,500 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $920,000 | -61.5% | 304,500 | -50.0% | 0.01% | -25.0% |
| Q1 2018 | $2,388,000 | +89.4% | 609,000 | +100.0% | 0.02% | 0.0% |
| Q4 2017 | $1,261,000 | -32.6% | 304,500 | 0.0% | 0.02% | -36.0% |
| Q3 2017 | $1,870,000 | -1.3% | 304,500 | 0.0% | 0.02% | -7.4% |
| Q2 2017 | $1,894,000 | -1.9% | 304,500 | 0.0% | 0.03% | -3.6% |
| Q1 2017 | $1,931,000 | +18.5% | 304,500 | 0.0% | 0.03% | +16.7% |
| Q4 2016 | $1,629,000 | -5.0% | 304,500 | 0.0% | 0.02% | -11.1% |
| Q3 2016 | $1,714,000 | +2.5% | 304,500 | 0.0% | 0.03% | +3.8% |
| Q2 2016 | $1,672,000 | -26.0% | 304,500 | 0.0% | 0.03% | -31.6% |
| Q1 2016 | $2,259,000 | -10.7% | 304,500 | 0.0% | 0.04% | -9.5% |
| Q4 2015 | $2,530,000 | -7.8% | 304,500 | 0.0% | 0.04% | -10.6% |
| Q3 2015 | $2,744,000 | -23.8% | 304,500 | +1.5% | 0.05% | -16.1% |
| Q2 2015 | $3,600,000 | +11.4% | 300,000 | 0.0% | 0.06% | +12.0% |
| Q1 2015 | $3,231,000 | +112.4% | 300,000 | 0.0% | 0.05% | +108.3% |
| Q4 2014 | $1,521,000 | +92.0% | 300,000 | 0.0% | 0.02% | +84.6% |
| Q3 2014 | $792,000 | -34.5% | 300,000 | 0.0% | 0.01% | -35.0% |
| Q2 2014 | $1,209,000 | -12.0% | 300,000 | 0.0% | 0.02% | -13.0% |
| Q1 2014 | $1,374,000 | +5.5% | 300,000 | 0.0% | 0.02% | 0.0% |
| Q4 2013 | $1,302,000 | +10.2% | 300,000 | 0.0% | 0.02% | +9.5% |
| Q3 2013 | $1,182,000 | +86.7% | 300,000 | 0.0% | 0.02% | +75.0% |
| Q2 2013 | $633,000 | +15.3% | 300,000 | 0.0% | 0.01% | +9.1% |
| Q1 2013 | $549,000 | – | 300,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |